You are here

Article info

Article menu

Download PDFPDF

Chronic obstructive pulmonary disease
Original article
Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease
Free

Authors

  • Daniel Kotz Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine, Institute of General Practice, University Düsseldorf, Düsseldorf, Germany Department of Family Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands Allergy & Respiratory Research Group, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK Cancer Research UK Health Behaviour Research Centre, University College London, London, UK PubMed articlesGoogle scholar articles
  • Wolfgang Viechtbauer MHeNS School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Colin R Simpson Allergy & Respiratory Research Group, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Onno C P van Schayck Department of Family Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands Allergy & Respiratory Research Group, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Robert West Cancer Research UK Health Behaviour Research Centre, University College London, London, UK PubMed articlesGoogle scholar articles
  • Aziz Sheikh Department of Family Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands Allergy & Respiratory Research Group, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Daniel Kotz, Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine, University Düsseldorf, Institute of General Practice, Düsseldorf 40225, Germany; Daniel.Kotz{at}med.uni-duesseldorf.de
View Full Text

Citation

Kotz D, Viechtbauer W, Simpson CR, et al
Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease
Thorax 2017;72:905-911.

Publication history

  • Received January 26, 2017
  • Revised March 17, 2017
  • Accepted April 4, 2017
  • First published May 4, 2017.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/